Interestingly, treatment with FRAX486 normalized the altered locomotor profile of CDD mice, restoring wt‐like levels (p < 0.01 for Cdkl5‐Het, ctrl vs. Cdkl5‐Het, FRAX486; Figure 2C). Here, CDKL5 is linked to craniodiaphyseal dysplasia.